University of Pittsburgh School of Medicine Department of Pharmacology & Chemical Biology

Home > Directory > Primary Faculty > Francisco J. Schopfer, PhD

Francisco J. Schopfer, PhD

Professor & Vice Chair for Biotechnology Development

E1343 Thomas E. Starzl Biomedical Science Tower
200 Lothrop Street
Pittsburgh, PA 15213

fjs2@pitt.edu

Phone: 412-648-0193

Fax: 412-648-2229

Education

BS/MS (Biology), University of Buenos Aires, Argentina, 1998
PhD (Biochemistry), University of Buenos Aires, Argentina, 2001
MBA, University of Pittsburgh, 2011

Labs

Schopfer Lab

Research Areas

Dr. Schopfer’s research is focused on the understanding of the biological effects of electrophilic fatty acids. In particular, he studies the mechanism by which nitrated fatty acid activate and signal through peroxisome proliferator-activated receptor gamma (PPARγ). This receptor is the target of currently used antidiabetic drugs (thiazolidinediones). The activation of the receptor regulates fat and glucose metabolism, resulting in an overall decrease of glucose levels to normal values in patients with type II diabetes. The targeting of this receptor by nitrated fatty acids results in a decrease of the glucose levels to normal values like thiazolidinediones, but without the known secondary effects exerted by thiazolidinediones. In addition to the intrinsic therapeutic value of nitrated fatty acid, they will aid in the understanding of the biological mechanism involved in PPARγ activation, leading to improved designs of anti-diabetic drugs targeting the PPARγ receptor.

Fig 1. Modeling of PPARγ receptor activation by nitrated oleic acid

Biological effects of endogenous PPARϒ ligands

The role of the PPARγ receptor in diabetes has been well established. Nonetheless, the role of endogenous signaling molecules on the activation of PPARϒ is still unclear and under debate. Nitrated fatty acids are endogenously formed and bind to PPARγ with high affinity rivaling Rosiglitazone (thiazolidinediones), resulting in receptor activation. In addition, nitrated fatty acids covalently modify a critical cysteine (cys285) in the ligand binding pocket of PPARγ promoting a particular conformational change that results in partial receptor activation. This partial activation results in the expression of a particular subset of genes under PPARγ regulation and a biological outcome that differs from the one obtained when activating the receptor with Rosiglitazone. Dr. Schopfer’s work focuses on understanding the mechanism of this selective activation and how it avoids the side effect presented upon full activation by agonist like Rosiglitazone.

Endogenous formation of electrophiles and biological relevance

Electrophilic fatty acids are constantly formed as fatty acid breakdown products during oxidative stress and as signaling messengers by enzymatic or non enzymatic pathways. Dr. Schopfer studies the formation of biologically relevant electrophiles, in particular nitrated fatty acids, and their signaling mechanisms. The study involves the detection and characterization of novel electrophiles formed during inflammation. Once the molecules are characterized, a chemical synthesis approach is used to generate enough quantities for biological experiments.

Fig 2 A Key Reactivity of nitrated fatty acids: rapid, reversible Michael Addition reactions.

Proteomic analysis of electrophilic post-translational modifications

Electrophiles induce an important cellular response that includes the induction of phase II genes. This will in turn set up a more protective environment against damaging electrophilic molecules. A key player in the initiation of this biological response is the Keap 1/Nrf 2 couple. Keap 1 is usually bound to Nrf 2 in the cytoplasm. Upon formation of electrophiles, Keap 1, which contains several highly reactive cysteine, is targeted, dissociates from Nrf2 and is routed to degradation by the proteosome. These lead to Nrf2 nuclear translocation and activation of phase II genes. In particular, we study the mechanism by which different biologically relevant electrophiles target KEAP 1 and activate Nrf 2 responses. In addition, a more general proteomic approach is use to evaluate and characterize different electrophilic cellular protein targets. Once critical targets are identified using a mass spectrometry approach, a functional study of the modification is performed to determine the relevance and its cellular effects.

Journal Articles

Jobbagy S, DA Vitturi, SR Salvatore, L Turell, MF Pires, E Kansanen, C Batthyany, JR Lancaster, Jr., BA Freeman and FJ Schopfer. Electrophiles modulate glutathione reductase activity via alkylation and upregulation of glutathione biosynthesis. Redox Biol 21, 101050, 2019.

Fazzari M, DA Vitturi, SR Woodcock, SR Salvatore, BA Freeman and FJ Schopfer. Electrophilic fatty acid nitroalkenes are systemically transported and distributed upon esterification to complex lipids. J Lipid Res 60:388-399, 2019.

Hansen AL, GJ Buchan, M Ruhl, K Mukai, SR Salvatore, E Ogawa, SD Andersen, MB Iversen, AL Thielke, C Gunderstofte, M Motwani, CT Moller, AS Jakobsen, KA Fitzgerald, J Roos, R Lin, TJ Maier, R Goldbach-Mansky, CA Miner, W Qian, JJ Miner, RE Rigby, J Rehwinkel, MR Jakobsen, H Arai, Y Taguchi, FJ Schopfer, D Olagnier and CK Holm. Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling. Proc Natl Acad Sci U S A 115:E7768-E7775, 2018,

Prentice KJ, SG Wendell, Y Liu, JA Eversley, SR Salvatore, H Mohan, SL Brandt, AC Adams, X Serena Wang, D Wei, GA FitzGerald, TB Durham, CD Hammond, KW Sloop, C Skarke, FJ Schopfer and MB Wheeler. CMPF, a metabolite formed upon prescription omega-3-acid ethyl ester supplementation, prevents and reverses steatosis. EBioMedicine 27:200-213, 2018,

Turell L, DA Vitturi, EL Coitino, L Lebrato, MN Moller, C Sagasti, SR Salvatore, SR Woodcock, B Alvarez and FJ Schopfer. The chemical basis of thiol addition to nitro-conjugated linoleic acid, a protective cell-signaling lipid. J Biol Chem 292:1145-1159, 2017.

Fazzari M, N Khoo, SR Woodcock, L Li, BA Freeman and FJ Schopfer.Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides. Free Radic Biol Med 87:113-124, 2015.

Vitturi DA, L Minarrieta, SR Salvatore, EM Postlethwait, M Fazzari, G Ferrer-Sueta, JR Lancaster, Jr., BA Freeman and FJ Schopfer. Convergence of biological nitration and nitrosation via symmetrical nitrous anhydride. Nat Chem Biol 11:504-510, 2015.

Vitturi DA, CS Chen, SR Woodcock, SR Salvatore, G Bonacci, JR Koenitzer, NA Stewart, N Wakabayashi, TW Kensler, BA Freeman and FJ Schopfer. Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase. J Biol Chem 288:25626-25637, 2013.

Bonacci G, PR Baker, SR Salvatore, D Shores, NK Khoo, JR Koenitzer, DA Vitturi, SR Woodcock, F Golin-Bisello, MP Cole, S Watkins, C St Croix, CI Batthyany, BA Freeman and FJ Schopfer. Conjugated linoleic acid is a preferential substrate for fatty acid nitration. J Biol Chem 287:44071-44082, 2012.

Groeger AL, C Cipollina, MP Cole, SR Woodcock, G Bonacci, TK Rudolph, V Rudolph, BA Freeman and FJ Schopfer. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 6:433-441, 2010.

Reviews

Hansen AL, K Mukai, FJ Schopfer, T Taguchi and CK Holm. STING palmitoylation as a therapeutic target. Cell Mol Immunol 16:236-241, 2019.

Schopfer FJ and NKH Khoo. Nitro-fatty acid logistics: Formation, biodistribution, signaling, and pharmacology. Trends Endocrinol Metab 30:505-519, 2019.

Schopfer FJ, DA Vitturi, DK Jorkasky and BA Freeman. Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases. Nitric Oxide 79:31-37, 2018,

Freeman BA, VB O'Donnell and FJ Schopfer. The discovery of nitro-fatty acids as products of metabolic and inflammatory reactions and mediators of adaptive cell signaling. Nitric Oxide 77:106-111, 2018.

Schopfer FJ, C Cipollina and BA Freeman. Formation and signaling actions of electrophilic lipids. Chem Rev 111:5997-6021, 2011.